|
Status |
Public on May 31, 2018 |
Title |
Next Generation Sequencing Facilitates Quantitative Analysis for Chromatin Immunoprecipitation of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
CRISPRi targeting PVT1 specifically increased H3K9me3 at PVT1
|
|
|
Overall design |
ChIP performed with biological replicates for CRISPRi-PVT1 with H3K9me3, H3K27ac, HA-dCas9-KRAB
|
|
|
Contributor(s) |
Cho SW, Chang HY |
Citation(s) |
29731168 |
|
Submission date |
Apr 10, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Howard Y. Chang |
E-mail(s) |
howchang@stanford.edu
|
Phone |
650-725-7022
|
Organization name |
Stanford
|
Lab |
Chang Lab
|
Street address |
269 Campus Drive, CCSR 2130
|
City |
Stanford |
State/province |
CALIFORNIA |
ZIP/Postal code |
94305 |
Country |
USA |
|
|
Platforms (1) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
Samples (24)
|
|
This SubSeries is part of SuperSeries: |
GSE97669 |
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element |
|
Relations |
BioProject |
PRJNA382388 |
SRA |
SRP103776 |